Concepedia

Francesca Conway

FC

Statistics

Publications

12

Citations

1.6K

H-Index

11

Active since

2015

Affiliations

Imperial College London(Current)

Royal Brompton Hospital

University of Oxford

University of Nottingham

University of Bristol

Francesca Conway is an author at Imperial College London specializing in internal medicine, pharmacotherapy, and 28-day mortality.

ORCID

Publications per year

2015–2024

12

Publications

12

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

, , +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

, , +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

, , +13

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 132 citations · Full text

, , +17

Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care

Pallav L. Shah, Christopher M. Orton, Beatriz Grinsztejn et al. · The Lancet Respiratory Medicine · 2022 · 57 citations · Full text

, , +11

1–5 of 12